Citations (77)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Emilie Anduran, Ludwig J Dubois, Philippe Lambin & Jean-Yves Winum. (2022) Hypoxia-activated prodrug derivatives of anti-cancer drugs: a patent review 2006 – 2021. Expert Opinion on Therapeutic Patents 32:1, pages 1-12.
Read now
Read now
Constantinos Koumenis, Christine Naczki, Marianne Koritzinsky, Sally Rastani, Alan Diehl, Nahum Sonenberg, Antonis Koromilas & Bradly G. Wouters. (2002) Regulation of Protein Synthesis by Hypoxia via Activation of the Endoplasmic Reticulum Kinase PERK and Phosphorylation of the Translation Initiation Factor eIF2α. Molecular and Cellular Biology 22:21, pages 7405-7416.
Read now
Read now
Gregg L. Semenza. (2000) Hypoxia, Clonal Selection, and the Role of HIF-1 in Tumor Progression. Critical Reviews in Biochemistry and Molecular Biology 35:2, pages 71-103.
Read now
Read now
RM Phillips. (1998) Prospects for bioreductive drug development. Expert Opinion on Investigational Drugs 7:6, pages 905-928.
Read now
Read now
Cornelius Schmaltz, Patricia Harrigan Hardenbergh, Audrey Wells & David E. Fisher. (1998) Regulation of Proliferation-Survival Decisions during Tumor Cell Hypoxia. Molecular and Cellular Biology 18:5, pages 2845-2854.
Read now
Read now
Kolbein Sundfør, Heidi Lyng & Einar K. Rofstad. (1998) Oxygen Tension and Vascular Density in Adenocarcinoma and Squamous Cell Carcinoma of the Uterine Cervix. Acta Oncologica 37:7-8, pages 665-670.
Read now
Read now
Ralph E. Durand & Nancy E. Lepard. (1995) Contribution of Transient Blood Flow to Tumour Hypoxia in Mice. Acta Oncologica 34:3, pages 317-323.
Read now
Read now
Articles from other publishers (70)
Géraldine Gonon, Sonia M. de Toledo, Venkatachalam Perumal, Jean-Paul Jay-Gerin & Edouard I. Azzam. (2022) Impact of the redox environment on propagation of radiation bystander effects: The modulating effect of oxidative metabolism and oxygen partial pressure. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 883-884, pages 503559.
Crossref
Crossref
Jie Huang & Jian Jian Li. 2020. Tumor Microenvironment. Tumor Microenvironment
175
202
.
Mark W. Dewhirst & Timothy W. Secomb. (2017) Transport of drugs from blood vessels to tumour tissue. Nature Reviews Cancer 17:12, pages 738-750.
Crossref
Crossref
Jian Jian Li. 2017. Advances in Radiation Oncology. Advances in Radiation Oncology
191
221
.
Xiaomeng Zhang, Jonathan W. Wojtkowiak, Gary V. Martinez, Heather H. Cornnell, Charles P. Hart, Amanda F. Baker & Robert Gillies. (2016) MR Imaging Biomarkers to Monitor Early Response to Hypoxia-Activated Prodrug TH-302 in Pancreatic Cancer Xenografts. PLOS ONE 11:5, pages e0155289.
Crossref
Crossref
Xin Sun, Taiwei Chu & Xiangyun Wang. (2010) Preliminary studies of 99mTc-BnAO and its analogues: synthesis, radiolabeling and in vitro cell uptake. Nuclear Medicine and Biology 37:2, pages 117-123.
Crossref
Crossref
Sean M. McBride & Daphne A. Haas-Kogan. 2010. Pediatric CNS Tumors. Pediatric CNS Tumors
313
334
.
Sandip Basu & Abass Alavi. (2009) Molecular Imaging (PET) of Brain Tumors. Neuroimaging Clinics of North America 19:4, pages 625-646.
Crossref
Crossref
Jessica A. Bertout, Shetal A. Patel & M. Celeste Simon. (2008) The impact of O2 availability on human cancer. Nature Reviews Cancer 8:12, pages 967-975.
Crossref
Crossref
Michael F. Goldberg, Sanjeev Chawla, Abass Alavi, Drew A. Torigian & Elias R. Melhem. (2008) PET and MR Imaging of Brain Tumors. PET Clinics 3:3, pages 293-315.
Crossref
Crossref
Lincoln A. Edwards, Janet Woo, Lynsey A. Huxham, Maite Verreault, Wieslawa H. Dragowska, Gigi Chiu, Ashish Rajput, Alastair H. Kyle, Jessica Kalra, Donald Yapp, Hong Yan, Andrew I. Minchinton, David Huntsman, Tim Daynard, Dawn N. Waterhouse, B. Thiessen, Shoukat Dedhar & Marcel B. Bally. (2008) Suppression of VEGF secretion and changes in glioblastoma multiforme microenvironment by inhibition of Integrin-linked kinase (ILK). Molecular Cancer Therapeutics 7:1, pages 59-70.
Crossref
Crossref
Maria V. Papadopoulou, William D. Bloomer, Alice P. Taylor, Marisol Hernandez, Rosalyn D. Blumenthal & Melinda G. Hollingshead. (2007) Advantage of Combining NLCQ-1 (NSC 709257) with Radiation in Treatment of Human Head and Neck Xenografts. Radiation Research 168:1, pages 65-71.
Crossref
Crossref
Donald T.T. Yapp, Janet Woo, Aileen Kartono, Jonathan Sy, Thomas Oliver, Kirsten A. Skov, Cameron J. Koch, Hans Adomat, Wieslawa H. Dragowska, Ladan Fadzli, Thomas Ruth, Michael J. Adam, David Green & Martin Gleave. (2007)
Non-invasive evaluation of tumour hypoxia in the Shionogi tumour model for prostate cancer with
18
F-EF5 and positron emission tomography
. BJU International 99:5, pages 1154-1160.
Crossref
Crossref
Jennifer K. Chen, Lily J. Hu, Dongfang Wang, Kathleen R. Lamborn & Dennis F. Deen. (2007) Cytosine Deaminase/5-Fluorocytosine Exposure Induces Bystander and Radiosensitization Effects in Hypoxic Glioblastoma Cells in vitro. International Journal of Radiation Oncology*Biology*Physics 67:5, pages 1538-1547.
Crossref
Crossref
. (2006) Pharmacodynamics of Tirapazamine in Histocultures of a Human Lung Adenocarcinoma Xenograft. Journal of Korean Pharmaceutical Sciences 36:4, pages 231-237.
Crossref
Crossref
Eva GottfriedLeoni A. Kunz-SchughartStephanie EbnerWolfgang Mueller-KlieserSabine HovesReinhard AndreesenAndreas MackensenMarina Kreutz. (2006) Tumor-derived lactic acid modulates dendritic cell activation and antigen expression. Blood 107:5, pages 2013-2021.
Crossref
Crossref
Nils D. Arvold, Neela Guha, Dongfang Wang, Mary Matli, Dennis F. Deen, Robert S. Warren & Daphne A. Haas-Kogan. (2005) Hypoxia-induced radioresistance is independent of hypoxia-inducible factor-1A in vitro. International Journal of Radiation Oncology*Biology*Physics 62:1, pages 207-212.
Crossref
Crossref
Kirsten Skov, Hans Adomat, Mary Bowden, Wieslawa Dragowska, Martin Gleave, Cameron J. Koch, Janet Woo & Donald T. T. Yapp. (2004)
Hypoxia in the Androgen-Dependent Shionogi Model for Prostate Cancer at Three Stages
1
. Radiation Research 162:5, pages 547-553.
Crossref
Crossref
Mark T. Jennings, Anthony Cmelak, Mahlon D. Johnson, Paul L. Moots, Ray Pais & Yu Shyr. (2004) Differential responsiveness among “high risk” pediatric brain tumors in a pilot study of dose‐intensive induction chemotherapy. Pediatric Blood & Cancer 43:1, pages 46-54.
Crossref
Crossref
Victor M. Aquino, Steve D. Weitman, Naomi J. Winick, Susan Blaney, Wayne L. Furman, James L. Kepner, Peter Bonate, Mark Krailo, Wenchun Qu & Mark Bernstein. (2004) Phase I Trial of Tirapazamine and Cyclophosphamide in Children With Refractory Solid Tumors: A Pediatric Oncology Group Study. Journal of Clinical Oncology 22:8, pages 1413-1419.
Crossref
Crossref
Ralph E Durand & Christina Aquino-Parsons. (2004) Predicting response to treatment in human cancers of the uterine cervix: sequential biopsies during external beam radiotherapy. International Journal of Radiation Oncology*Biology*Physics 58:2, pages 555-560.
Crossref
Crossref
D. Haas-Kogan & B. M. Frisch. 2004. Pediatric CNS Tumors. Pediatric CNS Tumors
261
277
.
M. A. Rodriguez-Gabriel. (2003) RNA-binding protein Csx1 mediates global control of gene expression in response to oxidative stress. The EMBO Journal 22:23, pages 6256-6266.
Crossref
Crossref
Dawen Zhao, Sophia Ran, Anca Constantinescu, Eric W. Hahn & Ralph P. Mason. (2003) Tumor Oxygen Dynamics: Correlation of In Vivo MRI with Histological Findings. Neoplasia 5:4, pages 308-318.
Crossref
Crossref
Ian J. Stratford, Kaye J. Williams, Rachel L. Cowen & Mohammed Jaffar. (2003) Combining bioreductive drugs and radiation for the treatment of solid tumors. Seminars in Radiation Oncology 13:1, pages 42-52.
Crossref
Crossref
Ralph P. Mason, Sandeep Hunjan, Anca Constantinescu, Yulin Song, Dawen Zhao, Eric W. Hahn, Peter P. Antich & Peter Peschke. 2003. Oxygen Transport to Tissue XXIV. Oxygen Transport to Tissue XXIV
19
27
.
Yulin Song, Kate L. Worden, Xin Jiang, Dawen Zhao, Anca Constantinescu, Hanli Liu & Ralph P. Mason. 2003. Oxygen Transport to Tissue XXIV. Oxygen Transport to Tissue XXIV
225
236
.
Isaiah J Fidler, Junya Yoneda, Carlos Herrera, Jeanette Wood & Lei Xu. (2003) Specific Keynote: Molecular Determinants of Angiogenesis in Ovarian Cancer. Gynecologic Oncology 88:1, pages S29-S36.
Crossref
Crossref
Peggy L. Olive, Judit P. Banáth & Ralph E. Durand. (2002) The Range of Oxygenation in SiHa Tumor Xenografts. Radiation Research 158:2, pages 159-166.
Crossref
Crossref
Mona Diab-Assef, Makhluf J. Haddadin, Pierre Yared, Chafika Assaad & Hala U. Gali-Muhtasib. (2002) Quinoxaline 1,4-dioxides: Hypoxia-selective therapeutic agents. Molecular Carcinogenesis 33:4, pages 198-205.
Crossref
Crossref
Marita Bosticardo, Silvia Ariotti, Giuliana Losana, Paola Bernabei, Guido Forni & Francesco Novelli. (2001) Biased activation of human T lymphocytes due to low extracellular pH is antagonized by B7/CD28 costimulation. European Journal of Immunology 31:9, pages 2829-2838.
Crossref
Crossref
Sun-Hee Baek, U-Youn Lee, Eun-Mi Park, Mi-Young Han, Yun-Sil Lee & Young-Mee Park. (2001) Role of protein kinase C? in transmitting hypoxia signal to HSF and HIF-1. Journal of Cellular Physiology 188:2, pages 223-235.
Crossref
Crossref
M. Hockel & P. Vaupel. (2001) Tumor Hypoxia: Definitions and Current Clinical, Biologic, and Molecular Aspects. JNCI Journal of the National Cancer Institute 93:4, pages 266-276.
Crossref
Crossref
Bruce M. Fenton, Edith M. Lord & Scott F. Paoni. (2001) Effects of Radiation on Tumor Intravascular Oxygenation, Vascular Configuration, Development of Hypoxia, and Clonogenic Survival. Radiation Research 155:2, pages 360-368.
Crossref
Crossref
Mark T. Jennings & Sunita Iyengar. (2001) The Molecular Genetics of Therapeutic Resistance in Malignant Astrocytomas. American Journal of PharmacoGenomics 1:2, pages 93-99.
Crossref
Crossref
Ralph E Durand & Nancy E LePard. (2000) Effects of mitomycin C on the oxygenation and radiosensitivity of murine and human tumours in mice. Radiotherapy and Oncology 56:2, pages 245-252.
Crossref
Crossref
Marie Wiltshire, Laurence H. Patterson & Paul J. Smith. (2000) A novel deep red/low infrared fluorescent flow cytometric probe, DRAQ5NO, for the discrimination of intact nucleated cells in apoptotic cell populations. Cytometry 39:3, pages 217-223.
Crossref
Crossref
M. Molls, H. J. Feldmann, P. Stadler & R. Jund. 2000. Blood Perfusion and Microenvironment of Human Tumors. Blood Perfusion and Microenvironment of Human Tumors
81
87
.
C. W. Song. 2000. Blood Perfusion and Microenvironment of Human Tumors. Blood Perfusion and Microenvironment of Human Tumors
193
207
.
Hasrat Ali & Johan E. van Lier. (1999) Metal Complexes as Photo- and Radiosensitizers. Chemical Reviews 99:9, pages 2379-2450.
Crossref
Crossref
E K Rofstad & T Danielsen. (1999) Hypoxia-induced metastasis of human melanoma cells: involvement of vascular endothelial growth factor-mediated angiogenesis. British Journal of Cancer 80:11, pages 1697-1707.
Crossref
Crossref
B M Fenton, S F Paoni, J Lee, C J Koch & E M Lord. (1999) Quantification of tumour vasculature and hypoxia by immunohistochemical staining and HbO2 saturation measurements. British Journal of Cancer 79:3-4, pages 464-471.
Crossref
Crossref
J Bussink, J.H.A.M Kaanders, P.F.J.W Rijken, J.P.W Peters, R.J Hodgkiss, H.A.M Marres & A.J van der Kogel. (1999) Vascular architecture and microenvironmental parameters in human squamous cell carcinoma xenografts: effects of carbogen and nicotinamide. Radiotherapy and Oncology 50:2, pages 173-184.
Crossref
Crossref
Benjamin Movsas, J.Donald Chapman, Eric M Horwitz, Wayne H Pinover, Richard E Greenberg, Alexandra L Hanlon, Renuka Iyer & Gerald E Hanks. (1999) Hypoxic regions exist in human prostate carcinoma. Urology 53:1, pages 11-18.
Crossref
Crossref
Xuan Yuan, Kevin Tabassi & Jeffery A. Williams. (1999) Implantable polymers for tirapazamine treatments of experimental intracranial malignant glioma. Radiation Oncology Investigations 7:4, pages 218-230.
Crossref
Crossref
S.M Raleigh, E Wanogho, M.Danny Burke, S.R McKeown & L.H Patterson. (1998) Involvement of human cytochromes P450 (CYP) in the reductive metabolism of AQ4N, a hypoxia activated anthraquinone DI-N-oxide prodrug. International Journal of Radiation Oncology*Biology*Physics 42:4, pages 763-767.
Crossref
Crossref
Atsuo Waki, Hitomi Kato, Ryoichi Yano, Norihiro Sadato, Akira Yokoyama, Yasushi Ishii, Yoshiharu Yonekura & Yasuhisa Fujibayashi. (1998) The importance of glucose transport activity as the rate-limiting step of 2-deoxyglucose uptake in tumor cells in vitro. Nuclear Medicine and Biology 25:7, pages 593-597.
Crossref
Crossref
Sarah S Donaldson, Margaret Torrey, Michael P Link, Arvin Glicksman, Louis Gilula, Fran Laurie, John Manning, James Neff, William Reinus, Elizabeth Thompson & Jonathan J Shuster. (1998) A multidisciplinary study investigating radiotherapy in Ewing’s sarcoma: end results of POG #8346. International Journal of Radiation Oncology*Biology*Physics 42:1, pages 125-135.
Crossref
Crossref
Jianling Yuan & Peter M. Glazer. (1998) Mutagenesis induced by the tumor microenvironment. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 400:1-2, pages 439-446.
Crossref
Crossref
Bruce M. Fenton, Scott F. Paoni, Cameron J. Koch & Edith M. Lord. 1998. Oxygen Transport to Tissue XX. Oxygen Transport to Tissue XX
619
628
.
Sara Rockwell & Marianne Kelley. (1998) RSR13, a synthetic allosteric modifier of hemoglobin, as an adjunct to radiotherapy:Preliminary studies with EMT6 cells and tumors and normal tissues in mice. Radiation Oncology Investigations 6:5, pages 199-208.
Crossref
Crossref
Robert M. Cardinale, Larry E. Dillehay, Jeffery A. Williams, Kevin Tabassi, Henry Brem & Ding-Jen Lee. (1998) Effect of interstitial and/or systemic delivery of tirapazamine on the radiosensitivity of human glioblastoma multiforme in nude mice. Radiation Oncology Investigations 6:2, pages 63-70.
Crossref
Crossref
B Dubray, JJ Pavy, P Giraud, S Danhier & JM Cosset. (1997) Les tests prédictifs de la réponse à la radiothérapie: bilan et perspectives en 1997. Cancer/Radiothérapie 1:5, pages 473-483.
Crossref
Crossref
E Lartigau. (1997) De la biologie à la radiothérapie: état des lieux et perspectives d'avenir. Cancer/Radiothérapie 1:5, pages 471-472.
Crossref
Crossref
Turi Danielsen, Rubi Skøyum & Einar K. Rofstad. (1997) Hypoxia-induced changes in radiation sensitivity in human melanoma cells: importance of oxygen-regulated proteins, adenylate energy charge and cell cycle distribution. Radiotherapy and Oncology 44:2, pages 177-182.
Crossref
Crossref
Ralph E Durand & Nancy E LePard. (1997) Tumour blood flow influences combined radiation and doxorubicin treatments. Radiotherapy and Oncology 42:2, pages 171-179.
Crossref
Crossref
Dennis Le, Ralph P. Mason, Sandeep Hunjan, Anca Constantinescu, Bruce R. Barker & Peter P. Antich. (1997) Regional tumor oxygen dynamics: 19F PBSR EPI of hexafluorobenzene. Magnetic Resonance Imaging 15:8, pages 971-981.
Crossref
Crossref
Philip J. Bergman & Dee Harris. (1997) Radioresistance, Chemoresistance, and Apoptosis Resistance. Veterinary Clinics of North America: Small Animal Practice 27:1, pages 47-57.
Crossref
Crossref
S. Rockwell & J. P. S. Knisely. 1996. Regulation of Angiogenesis. Regulation of Angiogenesis
335
360
.
M. A. J. Chaplain. 1997. A Survey of Models for Tumor-Immune System Dynamics. A Survey of Models for Tumor-Immune System Dynamics
187
236
.
R.K. Kale. (1996) Exploitation of hypoxia for radiation therapy: A lesson from phenothiazines. Medical Hypotheses 47:2, pages 107-110.
Crossref
Crossref
Ralph P. Mason, Watchara Rodbumrung & Peter P. Antich. (1996) Hexafluorobenzene: a Sensitive19F NMR Indicator of Tumor Oxygenation. NMR in Biomedicine 9:3, pages 125-134.
Crossref
Crossref
M.A.J. Chaplain. (1996) Avascular growth, angiogenesis and vascular growth in solid tumours: The mathematical modelling of the stages of tumour development. Mathematical and Computer Modelling 23:6, pages 47-87.
Crossref
Crossref
Adrian L. Harris, Huatang Zhang, Amir Moghaddam, Steve Fox, Prudence Scott, Adam Pattison, Kevin Gatter, Ian Stratford & Roy Bicknell. (1996) Breast cancer angiogenesis — new approaches to therapy via antiangiogenesis, hypoxic activated drugs, and vascular targeting. Breast Cancer Research and Treatment 38:1, pages 97-108.
Crossref
Crossref
Toru Shibata, Yuta Shibamoto, Keisuke Sasai, Natsuo Oya, Rumi Murata, Takehisa Takagi, Masahiro Hiraoka & Mitsuyuki Abe. (2005)
Comparison of
in vivo
Efficacy of Hypoxic Cytotoxin Tirapazamine and Hypoxic Cell Radiosensitizer KU‐2285 in Combination with Single and Fractionated Irradiation
. Japanese Journal of Cancer Research 87:1, pages 98-104.
Crossref
Crossref
J. Martin Brown & Bronwyn G. Siim. (1996) Hypoxia-specific cytotoxins in cancer therapy. Seminars in Radiation Oncology 6:1, pages 22-36.
Crossref
Crossref
Colin M. Archer, Barbara Edwards & Nigel A. Powell. 1996. Current Directions in Radiopharmaceutical Research and Development. Current Directions in Radiopharmaceutical Research and Development
81
88
.
Mark A. J. Chaplain & Michelle E. Orme. 1996. Vascular Morphogenesis: In Vivo, In Vitro, In Mente. Vascular Morphogenesis: In Vivo, In Vitro, In Mente
205
240
.
William R. Wilson & Frederik B. Pruijn. (2007) Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists, 1994: HYPOXIA‐ACTIVATED PRODRUGS AS ANTITUMOUR AGENTS: STRATEGIES FOR MAXIMIZING TUMOUR CELL KILLING. Clinical and Experimental Pharmacology and Physiology 22:11, pages 881-885.
Crossref
Crossref
David J. Brenner, Lynn R. Hlatky, Philip J. Hahnfeldt, Eric J. Hall & Rainer K. Sachs. (1995) A convenient extension of the linear-quadratic model to include redistribution and reoxygenation. International Journal of Radiation Oncology*Biology*Physics 32:2, pages 379-390.
Crossref
Crossref